My watch list
my.bionity.com  
Login  
NEWS
Current news

Diseases of another kind

The drought that has the entire country in its grip is affecting more than the color of people's lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such as lakes, rivers and hot springs, which the drought has made warmer ... more

New view of stomach cancer could hasten better therapies

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities. They say the new classification promises to advance ... more

Rigid connections: Molecular basis of age-related memory loss explained

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of scientists around Associate Prof Dr Antonio Del Sol Mesa from the Luxembourg Centre for ... more

Dangers of desert dust: New diagnostic tool for valley fever

On July 5, 2011, a massive wall of dust, ("haboob," in Arabic), blanketed Phoenix, Arizona, creating an awesome spectacle, (or stubborn nuisance, depending on your perspective). Dust storms are a common occurrence in the arid desert environments of the American Southwest. But windborne dust ... more

Study links autistic behaviors to enzyme

Fragile X syndrome ( FXS ) is a genetic disorder that causes obsessive-compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It is the most common inherited cause of mental impairment and the most common cause of autism. Now biomed ... more

Zenith Epigenetics Appoints Julie Cherrington as President and CEO

Zenith Epigenetics Corp. announced that it has appointed Julie Cherrington PhD to act as the President and Chief Executive Officer of Zenith Epigenetics Corp. Julie has an extensive background leading companies focused on the discovery and development of novel cancer therapeutics and is wel ... more

GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis

GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to i ... more

Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement

Evogene Ltd. and Marrone Bio Innovations Inc. announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the co ... more

Industry Innovation Index External Knowledge – Underestimated Potential for Innovation

Globalization and short product life cycles are increasing the pressure on companies to open up their innovation processes. However, currently German industrial managers rate the use of external knowledge as least relevant for successful innovation. Only seven percent make a conscious effor ... more

DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology

DuPont Pioneer announced that Neal Gutterson, Ph.D., will join the business as vice president of Agricultural Biotechnology (ABT), effective July 21, 2014. Gutterson joins Pioneer from Mendel Biotechnology where he served most recently as president, chief executive officer and board member. ... more

All news

Zenith Epigenetics Appoints Julie Cherrington as President and CEO

Zenith Epigenetics Corp. announced that it has appointed Julie Cherrington PhD to act as the President and Chief Executive Officer of Zenith Epigenetics Corp. Julie has an extensive background leading companies focused on the discovery and development of novel cancer therapeutics and is wel ... more

GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis

GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to i ... more

Ötzi’s “non-human” DNA

Ötzi’s human genome was decoded from a hip bone sample taken from the 5,300 year old mummy. However the tiny sample weighing no more than 0.1 g provides so much more information. A team of scientists from EURAC in Bolzano/Bozen together with colleagues from the University of Vienna successf ... more

Pseudogenes may provide clearer understanding of biomarkers

Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. Not any mor ... more

Identifying microbial species

Millions of microbial species populate the world, but so far only a few have been identified due to the inability of most microbes to grow in the laboratory. Edgar Goluch, an engineer, and Slava Epstein, a biologist, aim to change this. The pair, both researchers at Northeastern University, ... more

Prototype electrolyte sensor to provide immediate read-outs

Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.Runners, athletes in other strenuous sports ... more

Agilent Technologies Thought Leader Award Supports Dr. Carolyn Mountford

Agilent Technologies Inc. announced that Dr. Carolyn Mountford has received an Agilent Thought Leader Award in recognition of her work using nuclear magnetic resonance (NMR) spectroscopy technology in cancer research.Dr. Mountford is a professor of radiology at The University of Newcastle A ... more

analytica closes with outstanding results in all areas

Despite a pilot strike, visitors from around the world flocked to the trade-fair center in Munich during the past four days. The reason: the 24th analytica. The trade fair for laboratory technology, analysis and biotechnology attracted more than 34,400 visitors to Munich (compared to 30,481 ... more

Tracing how the embryo takes over

Embryonic development is initially controlled by maternal genetic information stored in the egg. LMU researchers now describe a methodology that allows the succeeding activation of the zygotic genome to be mapped at high resolution. In multicellular organisms, the earliest steps in embryoni ... more

analytica 2014 to focus on food and plastics analysis, genetic analysis and bioanalysis

A first-rate and exciting program of events awaits visitors at the 24th analytica in Munich. From April 1 – 4, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology will once again be a center for key players in science and industry. More than 1,100 exhibitors w ... more

All news on bioanalytics

Diseases of another kind

The drought that has the entire country in its grip is affecting more than the color of people's lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such as lakes, rivers and hot springs, which the drought has made warmer ... more

New view of stomach cancer could hasten better therapies

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities. They say the new classification promises to advance ... more

Rigid connections: Molecular basis of age-related memory loss explained

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of scientists around Associate Prof Dr Antonio Del Sol Mesa from the Luxembourg Centre for ... more

Study links autistic behaviors to enzyme

Fragile X syndrome ( FXS ) is a genetic disorder that causes obsessive-compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It is the most common inherited cause of mental impairment and the most common cause of autism. Now biomed ... more

Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement

Evogene Ltd. and Marrone Bio Innovations Inc. announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the co ... more

DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology

DuPont Pioneer announced that Neal Gutterson, Ph.D., will join the business as vice president of Agricultural Biotechnology (ABT), effective July 21, 2014. Gutterson joins Pioneer from Mendel Biotechnology where he served most recently as president, chief executive officer and board member. ... more

Scientists map one of most important proteins in life - and cancer

Scientists reveal the structure of one of the most important and complicated proteins in cell division – a fundamental process in life and the development of cancer – in research published in Nature. Images of the gigantic protein in unprecedented detail will transform scientists' understan ... more

Decoding dengue

Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics. For years, the conventional approach to target the dengue vi ... more

PBL awared further US patents on short RNAi molecules

Plant Bioscience Limited (PBL) announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 8,759,102 and US Patent No. 8,779,236 with fundamental claims directed to RNAi in cells and organisms to effect gene silencing. These two new patents granted add to t ... more

immatics receives €22 million final tranche of Series D fundraising

immatics biotechnologies GmbH announced that it has received €22m to complete a Series D financing round. The Company received €12m in October 2013 as an initial tranche of the total €34m funding round. The Series D funding was supported by existing investors including dievini Hopp Biotech ... more

All news on biotechnology

Dangers of desert dust: New diagnostic tool for valley fever

On July 5, 2011, a massive wall of dust, ("haboob," in Arabic), blanketed Phoenix, Arizona, creating an awesome spectacle, (or stubborn nuisance, depending on your perspective). Dust storms are a common occurrence in the arid desert environments of the American Southwest. But windborne dust ... more

New blood test identifies risk “Sudden Cardiac Death”

UAntwerp (University of Antwerp), UZA (Antwerp University Hospital), and Multiplicom NV together developed a blood test to determine the genetic risk of “Sudden Cardiac Death” (SCD). This test, called PED MASTR, is already in use at the center of medical genetics of UZA/UAntwerp and will be ... more

Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test

Merck announced that the company has signed an agreement to collaborate with Sysmex Inostics GmbH for the development and commercialization of a blood-based RAS biomarker test for patients with metastatic colorectal cancer (mCRC). Blood-based biomarker testing is a faster and easier approac ... more

Studies Validate EKF Diagnostics’ Early Stage Test for Progressive Diabetic Kidney Disease

EKF Diagnostics confirmed the growing weight of independent scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease (DKD). EKF affirms that the markers can be reliably used as diagnostic tests to predict end-stage ren ... more

Research that more than meets the eye

The link between blood flow in the retina and the development of glaucoma can now be measured accurately for the first time. This was made possible by the further development of an established measurement method, optical coherence tomography (OCT), which enables the visual assessment of the ... more

Research combines graphene and painkiller receptor

Almost every biological process involves sensing the presence of a certain chemical. Finely tuned over millions of years of evolution, the body’s different receptors are shaped to accept certain target chemicals. When they bind, the receptors tell their host cells to produce nerve impulses, ... more

Exact outline of melanoma could lead to new diagnostic tools

Researchers at Oregon State University have identified a specific biochemical process that can cause normal and healthy skin cells to transform into cancerous melanoma cells, which should help predict melanoma vulnerability and could also lead to future therapies. More than 70,000 cases of ... more

First living organism that transmits added letters in DNA 'alphabet'

Scientists at The Scripps Research Institute (TSRI) have engineered a bacterium whose genetic material includes an added pair of DNA "letters," or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the m ... more

Electronic Nose Sniffs Out Prostate Cancer

We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between pro ... more

Emerging technologies redefine infectious disease diagnostics

The diagnostics market for infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus and human papilloma virus is expanding, giving rise to commercial opportunities especially in the developing economies of Asia, Africa and Latin America. The urgen ... more

All news on diagnostics

Merger of CyBio AG into Analytik Jena AG Completed

The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company. In the future, the Life Science business u ... more

LABVOLUTION – the new lab technology show in Hannover

Deutsche Messe is launching LABVOLUTION, a new trade fair to be staged every two years as amajor platform for the world of lab technology and equipment. LABVOLUTIONmakes its debut from 6 to 8 October 2015 at the Hannover Exhibition Center in Hannover, Germany, where it will take place every ... more

Automating Laboratory-On-A-Chip To Cut Healthcare Costs

A research team at the University of California, Riverside has created a computer programming language that will automate “laboratory-on-a-chip” technologies used in DNA sequencing, drug discovery, virus detection and other biomedical applications.“If you think of the beginning of computers ... more

Reorganization of the Executive Board of Eppendorf AG

The Executive Board of Eppendorf AG is reshaping in order to be optimally equipped to meet the future demands of the market. Dr. Dirk Ehlers, Chairman of the Executive Board of the Eppendorf Group, will leave the company by mutual agreement. Detmar Ammermann (Chief Financial Officer) will r ... more

New microscope sees what others can't

Microscopes don't exactly lie, but their limitations affect the truths they can tell. For example, scanning electron microscopes (SEMs) simply can't see materials that don't conduct electricity very well, and their high energies can actually damage some types of samples. In an effort to ext ... more

A lab in your pocket

When you get sick, your physician may take a sample of your blood, send it to the lab and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick— ... more

Sartorius with Gains

Sartorius got off to a good start in fiscal 2014, with gains in order intake and sales revenue. In constant currencies, Group sales revenue rose 6.3% and order intake increased 4.9%. Despite negative currency impacts, operating Profit for the Group also grew 2.0%; its respective margin afte ... more

Turning smart phones into microscopes

Australian scientists have invented a simple and cheap way of making a high-powered lens that can transform a smart phone into a high-resolution microscope. Costing less than a cent, the lenses promise a revolution in science and medicine in developing countries and remote areas. The lens f ... more

analytica Vietnam 2015: Vietnam's economy continues to grow

According to Germany Trade & Invest (GTAI), the German association for foreign investment and location marketing, Vietnam plans to become a modern industrial nation by the year 2020. In addition, the southeast Asian threshold country is currently negotiating free trade agreements, amongst o ... more

Eppendorf: Sales stable in 2013

In fiscal year 2013, the Eppendorf Group achieved sales of €502.7 million (prior year: €520.2 million). When adjusted for currency effects, sales were only slightly lower than in the previous year (-0.4%). Income from operations (EBIT) decreased to €93.8 million (prior year: €101.5 million) ... more

All news on lab technology

MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development

MorphoSys AG and Galapagos NV announced that the first program from their strategic alliance has advanced into preclinical development. MOR106 was realized based on a novel Galapagos target and MorphoSys' next-generation antibody library Ylanthia and will now be jointly developed in inflamm ... more

Merck Strengthens Commitment to Chinese Growth Market

Merck reiterated its commitment to investments in the Chinese market, strengthening a major pillar of its emerging markets growth strategy. Merck’s Executive Board met in Shanghai, a month before the groundbreaking of its new pharmaceutical plant in Nantong, which from 2017 will be the Grou ... more

Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam

UCB announced an important advance in its research and development pipeline with positive topline results from the latest Phase 3 study with brivaracetam. This study was designed to evaluate the efficacy and safety of brivaracetam (100 and 200 mg/day, without titration) compared to placebo, ... more

Dompe announces the FDA has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis

Dompe announces that rhNGF (Recombinant Human Nerve Growth Factor) has been designated as an orphan drug by the American Food and Drug Administration (FDA).The candidate drug, developed by the research of Dompe, has been designated as an orphan drug for the treatment of neurotrophic keratit ... more

Actelion delivers strong half year operational and financial results

Actelion Ltd announced its results for the first half of 2014: Product sales of CHF 993 million, up 17% at Constant Exchange Rates (CER), 11% excluding US rebate reversals Core earnings of CHF 421 million, up 35% at CER, 21% excluding US rebate reversals Core EPS of CHF 3.25, an increase o ... more

Preventing foodborne illness, naturally - with cinnamon

Seeking ways to prevent some of the most serious foodborne illnesses caused by pathogenic bacteria, two Washington State University scientists have found promise in an ancient but common cooking spice: cinnamon. Recent findings published in Food Control suggest Cinnamomum cassia oil can wor ... more

Crenezumab Phase II cognition data in Alzheimer’s disease presented

AC Immune announced the presentation of data from two phase II studies investigating whether crenezumab (anti beta-amyloid antibody) can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease (AD) by its partner Genentech, a member of the Roche Group. The ... more

Santhera Repositions Omigapil in Congenital Muscular Dystrophy

Santhera Pharmaceuticals announced the initiation of a clinical program with omigapil, a drug candidate in-licensed from Novartis and repositioned for therapeutic use in Congenital Muscular Dystrophy (CMD). The clinical development program will be initiated with a Phase I study in pediatric ... more

One injection stops diabetes in its tracks

—In mice with diet-induced diabetes— the equivalent of type 2 diabetes in humans —a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published today in the journal Nature, could lead to ... more

Novartis to license Google "smart lens" technology

Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global p ... more

All news on pharma

Diseases of another kind

The drought that has the entire country in its grip is affecting more than the color of people's lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such as lakes, rivers and hot springs, which the drought has made warmer ... more

New view of stomach cancer could hasten better therapies

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities. They say the new classification promises to advance ... more

Rigid connections: Molecular basis of age-related memory loss explained

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of scientists around Associate Prof Dr Antonio Del Sol Mesa from the Luxembourg Centre for ... more

Study links autistic behaviors to enzyme

Fragile X syndrome ( FXS ) is a genetic disorder that causes obsessive-compulsive and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. It is the most common inherited cause of mental impairment and the most common cause of autism. Now biomed ... more

New potential way to control spread of insect-borne disease

A cross-disciplinary team is calling for public discussion about a potential new way to solve longstanding global ecological problems by using an emerging technology called "gene drives." The advance could potentially lead to powerful new ways of combating malaria and other insect-borne dis ... more

Metabolic enzyme stops progression of most common type of kidney cancer

In an analysis of small molecules called metabolites used by the body to make fuel in normal and cancerous cells in human kidney tissue, a research team from the Perelman School of Medicine at the University of Pennsylvania identified an enzyme key to applying the brakes on tumor growth. Th ... more

Scientists map one of most important proteins in life - and cancer

Scientists reveal the structure of one of the most important and complicated proteins in cell division – a fundamental process in life and the development of cancer – in research published in Nature. Images of the gigantic protein in unprecedented detail will transform scientists' understan ... more

Decoding dengue

Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics. For years, the conventional approach to target the dengue vi ... more

How antioxidants can accelerate cancers, and why they don't protect against them

For decades, health-conscious people around the globe have taken antioxidant supplements and eaten foods rich in antioxidants, figuring this was one of the paths to good health and a long life. Yet clinical trials of antioxidant supplements have repeatedly dashed the hopes of consumers who ... more

Antibody halts cancer-related wasting condition

New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute. Many strategies have been tried to reverse ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE